Post by BioStock - Connecting Innovation and Capital

3 weeks, 2 billion-dollar deals — AlzeCure Pharma is on a roll. 🔥 First Eli Lilly and Company, now QuantumCell ApS. AlzeCure's CEO Martin Jönsson talks to BioStock about the new partner, lead candidate ACD856 and the deal momentum. Watch the full interview here: https://lnkd.in/gSZYbSBb